AVIR - Atea Pharmaceuticals, Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - AVIR (1593899)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear
7 results. Finviz - SEC - Yahoo - Stockcharts - Tradingview
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

D
2024-02-01
AVIRCorcoran AndreaSee RemarksS - Sale+OE$3.84-15,843670,208-2%-$60,915
D
2024-02-01
AVIRSommadossi Jean-PierrePres, CEO,, COBS - Sale+OE$3.85-56,9106,041,557-1%-$218,819
D
2024-02-01
AVIRHorga Maria ArantxaChief Medical OfficerS - Sale+OE$3.84-15,87025,664-38%-$60,963
D
2024-02-01
AVIRFoster WayneEVP, Chief Accounting OfficerS - Sale+OE$3.84-12,47720,857-37%-$47,904
D
2024-02-01
AVIRVavricka JohnChief Commercial OfficerS - Sale+OE$3.84-11,819104,023-10%-$45,420
D
2024-02-01
AVIRHammond Janet MjChief Development OfficerS - Sale+OE$3.84-14,02935,362-28%-$53,913
M
2022-11-11
AVIRBerger Franklin MDirS - Sale$5.15-41,666778,353-5%-$214,685

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top